Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist Aleix Cases;

Response to ¿Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis¿. Response to related letter José C. De La Flor; Esperanza Moral; Javier Deira; Tania Monzón; Francisco Valga; Cristina Albarracín; Miguel Rodeles;

Short-term effects of dapagliflozin on biomarkers of bone and mineral metabolism in patients with diabetic kidney disease: A prospective observational study Tugba Islek; Safak Mirioglu; Meltem Gursu; Rumeyza Kazancioglu; Metin Demirel; Sahabettin Selek; Omer Celal Elcioglu;